- Home
- SNTI vs VINE Comparison
SNTI vs VINE Comparison
Compare SNTI & VINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- VINE
- Stock Information
- Founded
- SNTI 2016
- VINE 2019
- Country
- SNTI United States
- VINE United States
- Employees
- SNTI N/A
- VINE N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- VINE Beverages (Production/Distribution)
- Sector
- SNTI Health Care
- VINE Consumer Staples
- Exchange
- SNTI Nasdaq
- VINE Nasdaq
- Market Cap
- SNTI 10.4M
- VINE 11.0M
- IPO Year
- SNTI N/A
- VINE 2021
- Fundamental
- Price
- SNTI $4.41
- VINE $0.63
- Analyst Decision
- SNTI Strong Buy
- VINE
- Analyst Count
- SNTI 1
- VINE 0
- Target Price
- SNTI $12.00
- VINE N/A
- AVG Volume (30 Days)
- SNTI 7.0M
- VINE 235.4K
- Earning Date
- SNTI 11-14-2024
- VINE 12-27-2024
- Dividend Yield
- SNTI N/A
- VINE N/A
- EPS Growth
- SNTI N/A
- VINE N/A
- EPS
- SNTI N/A
- VINE N/A
- Revenue
- SNTI N/A
- VINE $477,737.00
- Revenue This Year
- SNTI $254.47
- VINE N/A
- Revenue Next Year
- SNTI $169.66
- VINE N/A
- P/E Ratio
- SNTI N/A
- VINE N/A
- Revenue Growth
- SNTI N/A
- VINE N/A
- 52 Week Low
- SNTI $1.52
- VINE $0.25
- 52 Week High
- SNTI $16.94
- VINE $1.25
- Technical
- Relative Strength Index (RSI)
- SNTI 52.77
- VINE 44.38
- Support Level
- SNTI $4.62
- VINE $0.59
- Resistance Level
- SNTI $5.96
- VINE $0.78
- Average True Range (ATR)
- SNTI 1.63
- VINE 0.06
- MACD
- SNTI -0.14
- VINE -0.00
- Stochastic Oscillator
- SNTI 18.48
- VINE 22.80
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About VINE Fresh Vine Wine Inc.
Fresh Vine Wine Inc is a producer of low-carb, low-calorie premium wines in the United States. The company's wine collection features a California Cabernet Sauvignon, Pinot Noir, Chardonnay, California Rose wine, and a Limited Reserve Napa Cabernet.